The combination of echocardiography, N-terminal pro-B-type natriuretic peptide and pulmonary artery to ascending aorta diameter ratio predicted severe pulmonary hypertension in patients with COPD with ...

A study found that pulmonary hypertension often resolves within a year in premature infants with BPD, though many still ...

Doctors in Germany could have achieved a breakthrough as they treated a young girl suffering from a severe pulmonary condition that can lead to heart failure, by applying umbilical cord stem cell ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...

A 40-year-old woman who was once accustomed to frequent travel suddenly found herself struggling to breathe after just a few ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Pulmonic regurgitation is when blood leaks back into the heart from the pulmonary artery due to weakness in the pulmonary valve. It happens when a pulmonary valve does not close properly. The ...